Related Articles
Response to bevacizumab combination chemotherapy of malignant pleural effusions associated with non‑squamous non-small‑cell lung cancer
Effect of hydrothorax EGFR gene mutation and EGFR‑TKI targeted therapy on advanced non‑small cell lung cancer patients
Microsatellite DNA analysis does not distinguish malignant from benign pleural effusions
Analysis of further disease progression in metastatic non-small cell lung cancer: Implications for locoregional treatment
Direct sequencing and amplification refractory mutation system for epidermal growth factor receptor mutations in patients with non-small cell lung cancer